St. Petersburg International Economic Forum
21 June 2012
Leonid Melamed: Isolated oases of narrowly focused innovation in life sciences are not the way forward for Russia and represent a temporary fix at best – what is needed to drive truly transformational change are fully-integrated life sciences innovation clusters supported by an ecosystem of research and development, finance and other key success factors and specialized skill sets
RUSNANO and Domain to Collaborate on Investments in Health Sciences Projects
06 March 2012
RUSNANO and Domain Associates, a U.S. venture capital firm specializing in leading-edge life sciences technologies, today announced a partnership that will spur modernization of the Russian healthcare market by bringing next-generation pharmaceuticals, medical devices and diagnostics to Russia.
Failure to launch? Half of drugs rolled out since 2004 didn't live up to sales forecasts: report
22 January 2021
Pharma ad agencies weigh in with Biden vaccine campaign advice
21 January 2021
The pandemic and the pharmaceutical world
21 January 2021
Trial to evaluate inhaled COVID-19 therapy finishes enrolment
19 January 2021